- Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
-
Patoulias D, Papadopoulos C, Karagiannis A, Vassilikos V, Doumas M
- KMID: 2527147
- Endocrinol Metab.
- 2022 Feb;37(1):170-174.
- doi: 10.3803/EnM.2021.1296
Type 2 diabetes mellitus (T2DM) and cardiovascular disease are closely interconnected. We sought to determine the cardioprotective action of finerenone according to prior treatment with newer antidiabetics and glycemic status.... -
- CITED
-
- Close
- SHARE
-
- Close
